EichorEICHOR
Study identifier: NCT06153693 Synced from ClinicalTrials.gov · August 06, 2026
● Study status: Completed

Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension

Condition: Hypertension  ·  Sponsor: Mineralys Therapeutics Inc.

PhasePhase 3
Planned participants1083
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a Phase 3 trial to evaluate the BP-lowering effect of lorundrostat (an aldosterone synthase inhibitor) in subjects with uncontrolled and resistant hypertension taking between 2 and 5 anti-hypertensive (AHT) medications.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (184)

Advanced Cardiovascular, LLC - Alexander City OfficeAlexander City, Alabama, United States
Central Research Associates, IncBirmingham, Alabama, United States
Cardiology, P.C.Birmingham, Alabama, United States
Synexus (Radiant Research, Inc) - Alabama - Simon Williamson Clinic LocationBirmingham, Alabama, United States
G & L Research LLC - FoleyFoley, Alabama, United States
Accel Research Sites (ARS) - Birmingham Clinical Research UnitVestavia Hills, Alabama, United States
Del Sol ResearchTucson, Arizona, United States
Entertainment Medical Group, Inc.Beverly Hills, California, United States
Amicis Research Center - Granada HillsGranada Hills, California, United States
Amicis Research Center - NorthridgeGranada Hills, California, United States
Marvel Clinical Research, LLCHuntington Beach, California, United States
Amicis Research CenterNorthridge, California, United States

+ 172 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →